Takashi’s results suggest that the expression of L1 cell adhesion molecule (L1CAM) may be used as an important biomarker for identifying high-risk patients with poor prognosis and as a therapeutic target in GC [37]. The gene discussed is L1CAM; the disease is gastric cancer.